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29 Reliability and validity study of the sweat conductivity test in a
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This study evaluated the reliability and validity of the sweat conductivity test
between July and September 2010. We included CF patients and clinical suspicion
ones referred to sweat test after having signed the consent form approved by the
Ethics Committee. Sweat conductivity tests were performed with the Macroduct
system, Sweat-Chek Analyser and Gibson&Cooke (G&C) techniques. The cut
points for diagnosis were 90 and 60mmol/l, respectively. Reliability was veriﬁed
by the comparison of the conductivity measures done in the same day on both arms
of 81 patients. To validation, 129 conductivity measures were taken from the right
arm (RA) and compared to the chloride (Cl−) values found by G&C. In addition
to the descriptive statistics, we estimated Pearson’s r and Bland-Altman.
We included 129 patients with median age of 52 months (mo), 55% female,
60.5% white and 99.2% residents of RJ. Among the 42 CF, median age was 117.5mo
(13–229), 61.9% female and 52.4% white. Among the suspected CF patients median
age was 33mo (1–211), 51.7% were female and 64.4% white. Mean conductivity
on the RA was 68.41 (SD 46.49) and LA 66.88 (SD 43.52)mmol/l. Pearson’s r was
0.97 and the mean differences 1.53 (SD 10.69)mmol/l (95%CI: −19.43 to 22.49).
The mean conductivity on the RA of 129 patients was 70.17 (SD 45.6) and the
mean Cl− 36.75 (SD 37.58)mmol/l. Pearson’s r was 0.85, and the characteristics
of the test were sensitivity = 89%, speciﬁcity = 92%, PPV = 82.5% and NPV =
95.5%.
The sweat conductivity test should present higher sensitivity for CF screening in the
general population. For the CF clinical suspicion patients it has been demonstrated
to be an accurate diagnosis procedure.
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Between 2009 and 2010, we performed exams in volunteers who had signed the
consent form approved by ethics committee. Were included exams which minimum
stability of 30 seconds in the 4 phases: basal (A1), amiloride (A2), chloride free (B1)
and isoproterenol (B2). The summary measures were described and compared by
ANOVA and non-parametric tests and reproducibility veriﬁed by Pearson’s r and
Bland Altman. From the 127 exams, 64% (81) were performed on females mean age
28 years (SD 16) and median of 27 years (1 to 60), where 15% (19) on CF patients
and 85% (108) on volunteers. The mean (SD) and median (range) were respectively
30 (10) and 30 (12−47)mV in CF and 14 (8) and 14 (2−45)mV in volunteers for the
maximal basal nasal potential difference (PDmax); were 14 (8) and 11 (5−31) in CF
and 7 (4) and 6 (0−22) in volunteers for delta amiloride (Damil) and were 4 (6) and
5 (−11 − 13) in CF and 14 (7) and 12 (3−42) in volunteers for free chloride delta
(Dfree Cl). The differences between the mean and median values were statistically
signiﬁcant with p values <0.0001. The reliability analysis of repetitive measures of
22 volunteers revealed Pearson’s r of 0.79 for PDmax and 0.75 for Dfree Cl, both
with p values of <0.0001 and for the Bland-Altman method the differences were
−1.9 (95%CI: −14 − 10) for PDmax and 2.5 (95%CI: −9.6 − 14.7) for Dfree Cl.
The greater part of the observations was included in the ±2SD interval of
median difference. Besides the necessary correlations coming from changes in
the technique, we can achieve more precision in the reproducibility increasing the
number of examinations and increasing the control of all sources of variables.
31 Modiﬁed nasal catheter for measurement of nasal potential
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Nasal potential difference (NPD) measurement reﬂects changes in chloride transport
through respiratory epithelia of CF and non CF subjects. The limited NPD
test reproducibility however hampers the measurement’s usefulness as outcome
parameter. We explored whether repeatability is improved by measuring over a
larger contact area.
A catheter with a 360º contact area over 2 cm was designed. NPD was measured
simultaneously with this large contact area catheter at 3 cm depth under the turbinate
and the standard 8Fr side hole catheter on the nasal ﬂoor in the other nostril. NPD
was repeated after a median of 2 days (range 1−60) in 20 subjects.
Correlation between repeated measurement for total chloride secretion was sig-
niﬁcantly better with the large contact than with the standard side hole catheter
(R = 0.108 vs −0.689, p = 0.038); within-subject variance (26.7mV2 vs 220.1mV2)
and mean coefﬁcient of variation (35.2% vs 59.7%, p = 0.042) were lower. Power
calculations for a clinical trial using change in total chloride secretion as primary
endpoint favors the use of the large contact area catheter (nnt = 20 vs 40 for
a correction to 33% of the chloride secretion in normal subjects). Measurements
with the standard catheter resulted in more negative NPD during perfusion with
Ringer (13.5mV±7.2mV vs 10.0mV±4.4mV, p = .004), larger amiloride response
(+8.0mV±6.0mV vs +4.8mV±2.6mV, p = .003), and larger total chloride secretion
(−21.5mV±15.9mV vs −14mV±9.1mV, p = .011).
NPD measurements over a larger contact area, have a better reproducibility than
measurements done with the side hole catheter used routinely.
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Objectives: To evaluate AE during and after NPD, comparing 2 NPD techniques.
Methods: Healthy adults underwent NPD using (A) needle-calomel electrode or
(B) Ag-AgCl electrode on abraded skin. Marquat® catheter (end-hole) was placed
in the meatus inferior (MI) in both nostrils the same day. AE were checked during
and 48 h after NPD procedure. 16 healthy adults underwent NPD. 8/16 had both
tests (A+B), 7/16 only B and 1/16 only A. 3/9 with A had pain at needle insertion.
1/16 had throat pain at position 2 cm, despite catheter replacement. Sinusitis with
headache appeared in 3/24 tests in 2 adults. One had sinusitis after A+B, the other
had only B and refused A. In 6/15 NPD with B a crust was seen after skin abrasion.
One subject with a swollen eye for 1 day after test B, had itchy cheek and chin
after subsequent NPD in 1 nostril with A; 2nd nostril was not done for fear of an
allergic reaction.
Discussion: NPD is considered not painful, but some AE were seen. Needle
placement was more painful, but a crust was only seen with abrasion. Acute sinusitis
post NPD was seen in 2 adults, known with chronic sinusitis. Misplacement of
catheter in MM (entailing the sinus outﬂow) instead of MI could explain sinusitis
by oedema due to catheter manipulation and high perfusion. A swollen eye after
NPD can be due to catheter position at the ostium of the nasolacrimal duct, located
in MI, where oedema or retrograde ﬂow can lead to swelling of the eye. Itchy
skin suggested allergic reaction on the solutions. Skin prick tests were doubtful for
Ringer.
Conclusion: NPD catheter positioning in MI entails risks for AE. Catheter place-
ment on the nasal ﬂoor might prevent above mentioned features.
